Seeking Alpha

Eisai Co. Ltd. (ESALY.PK)

()

Comments on ESALY.PK

  • Healthcare Profits: Assessing Company Sensitivity to Obamacare [View article]
    How do explain the fact that US Pharma companies spend 2 - 3 times in BME (business development, advertising, marketing and lobbying)... More »
    Comment by E Nuff Sed
    Nov 2 23:03 pm |
    Rating: +1 0
  • Healthcare Profits: Assessing Company Sensitivity to Obamacare [View article]
    Listen Grandad. Pharma research is exactly like defense. In the past, the U.S. has defended the rest of the world because the other... More »
    Nov 1 22:19 pm |
    Rating: 0 0
  • Healthcare Profits: Assessing Company Sensitivity to Obamacare [View article]
    c smith: if you have that private pay data readily available for the other companies, that would be good data to share
    Comment by Richard Shaw
    Nov 1 11:03 am |
    Rating: 0 0
  • Healthcare Profits: Assessing Company Sensitivity to Obamacare [View article]
    c smith: nice point
    Comment by Richard Shaw
    Nov 1 10:40 am |
    Rating: 0 0
  • Healthcare Profits: Assessing Company Sensitivity to Obamacare [View article]
    A better measure of sensitivity to ObamaCare is percentage of revenue which is "private pay"; i.e.; that which is not publicly funded... More »
    Comment by c smith
    Oct 31 20:37 pm |
    Rating: +1 0
  • Healthcare Profits: Assessing Company Sensitivity to Obamacare [View article]
    Herbal or alternative or fringe etc. medications are not the issue. Hard science pharma (or a reasonable facsimile in view of the... More »
    Comment by searcher
    Oct 31 14:58 pm |
    Rating: +1 0
  • Healthcare Profits: Assessing Company Sensitivity to Obamacare [View article]
    I suspect the concern raised by the author is overblown. Other than adding more lives to be insured and saddling the taxpayer with more... More »
    Comment by skwestorange
    Oct 31 14:39 pm |
    Rating: +1 -1
  • Healthcare Profits: Assessing Company Sensitivity to Obamacare [View article]
    The FDA just sent a threatening letter to Dr. Weil for advocating use of an herbal preparation that many use and have reported benefit... More »
    Comment by Jade Queen
    Oct 31 12:18 pm |
    Rating: 0 -2
  • Healthcare Profits: Assessing Company Sensitivity to Obamacare [View article]
    grandad: we aren't suggesting what ought to be, just the way it has been and the consequence of the way it would become -- there is no... More »
    Comment by Richard Shaw
    Oct 31 09:33 am |
    Rating: +2 0
  • Healthcare Profits: Assessing Company Sensitivity to Obamacare [View article]
    Are you serious ? Why the hell should U.S. citizens pay more for drugs so that foreign companies can have money to do research. I don
    Comment by grandad
    Oct 31 09:19 am |
    Rating: +1 -2
  • Healthcare Profits: Assessing Company Sensitivity to Obamacare [View article]
    Thanks, Mr. Shaw, for the helpful note. "...the profitable private market in the U.S. has enabled much of the research and development... More »
    Oct 30 09:03 am |
    Rating: +2 0
  • SuperGen-Glaxo Deal Couldn't Have Come at a Better Time [View article]
    EP: I posted this at my blog. http://seekingalpha.com/instablog/353266-justin-m-hall/33329-update-on-supergen-supg-by-ep-vantage
    Comment by Justin M. Hall
    Oct 28 08:09 am |
    Rating: +1 0
  • SuperGen-Glaxo Deal Couldn't Have Come at a Better Time [View article]
    EP: Thank you for the article on SUPG. I like this company and view it as a decent early-stage play with plenty of cash. Justin
    Comment by Justin M. Hall
    Oct 28 08:05 am |
    Rating: +1 0
  • Small Cap Stocks Battling Brain Cancer [View article]
    I would be interested in receiving feedback from interested readers.
    Comment by Savitri Das
    Sep 8 21:44 pm |
    Rating: 0 0
  • Small Cap Stocks Battling Brain Cancer [View article]
    I am surprised that Oncolytics Biotech candidate Reolysin was not mentioned here. For more info. read this recent article from the... More »
    Comment by Savitri Das
    Sep 8 21:43 pm |
    Rating: 0 0